HNRNPA2B1 and central nervous system cancer: showed that the downregulation of hnRNPA2/B1 expression can lead to the inactivation of the AKT and STAT3 signaling pathways, which subsequently reduces the expression of B cell lymph-2 (Bcl-2), ultimately inhibiting the growth of glioma.